Historic! HIV Vaccine Approved for Human Clinical Trials
It is the first preventive HIV vaccine approved for clinical trials to use a whole HIV-1 virus, which has been both killed and genetically engineered, to activate immunity. In this way, the new vaccine is much like the killed whole virus vaccines that are successful against polio, rabies and influenza.
Other HIV vaccines currently in clinical human trials have largely focused on one specific component of HIV to trigger an immune response. Right now, there is no effective HIV vaccine.
“FDA approval for human clinical trials is an extremely significant milestone for our vaccine, which has the potential to save the lives of millions of people around the world by preventing HIV infection,” said Dr. Chil-Yong Kang, professor of virology at the Schulich School of Medicine and Dentistry at the University of Western Ontario, in a release.
The Canadian vaccine has yet to demonstrate any adverse side effects or risks to patients.
Such incredible news! Blame Canada…for saving millions upon millions of lives around the world!